Clinical Trial Update: Efficacy and Safety of Escitalopram for Prevention of Depression Induced by Peg-Interferon in Hepatitis C Patients [Phase 2]

View source ↗

Summary

Phase 2 trial assessing efficacy and safety of escitalopram for preventing depression induced by peg-interferon in Hepatitis C patients; study completed with po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C
• Major Depressive Disorder

Drugs mentioned

• Escitalopram (escitalopram)
• Peg-interferon (pegylated interferon alfa)

Snippet

Sponsor: Germans Trias i Pujol Hospital | Conditions: Major Depressive Disorder, Hepatitis C, Chronic | Phase 2 | Status: COMPLETED | Results posted: 2011-03-30